Ultrasis (LSE:ULT) Change In Receivables: £-0.83 Mil (TTM As of Jul. 2014)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ultrasis Change In Receivables?

Ultrasis LSE:ULT Change In Receivables is £-0.83 Mil as of Jul. 2014. The stock has 2 warning signs investors should review.

Ultrasis's change in receivables for the quarter that ended in Jul. 2014 was £-0.83 Mil. It means Ultrasis's Accounts Receivable increased by £0.83 Mil from Jul. 2013 to Jul. 2014 .

Ultrasis's change in receivables for the fiscal year that ended in Jul. 2014 was £-0.83 Mil. It means Ultrasis's Accounts Receivable increased by £0.83 Mil from Jul. 2013 to Jul. 2014 .

Ultrasis's Accounts Receivable for the quarter that ended in Jul. 2014 was £1.11 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ultrasis's Days Sales Outstanding for the six months ended in Jul. 2014 was 110.12.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ultrasis's liquidation value for the six months ended in Jul. 2014 was £-2.37 Mil.

Ultrasis  (LSE:ULT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ultrasis's Days Sales Outstanding for the quarter that ended in Jul. 2014 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1.106/1.833*91
=110.12

2. In Ben Graham's calculation of liquidation value, Ultrasis's accounts receivable are only considered to be worth 75% of book value:

Ultrasis's liquidation value for the quarter that ended in Jul. 2014 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.122-3.324+0.75 * 1.106+0.5 * 0.006
=-2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ultrasis Change In Receivables Related Terms

Ultrasis Change In Receivables Historical Data

* Premium members only.

The historical data trend for Ultrasis's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ultrasis Change In Receivables Chart

Ultrasis Annual Data
Trend Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.99 -0.31 0.65 0.19 -0.83

Ultrasis Semi-Annual Data
Jul96 Jul97 Jul98 Jul99 Jul00 Jul01 Jul02 Jul03 Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 -0.31 0.65 0.19 -0.83

Ultrasis Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Jul. 2014 was £-0.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of £-0.83 Mil mean?
Ultrasis (LSE:ULT) has a Change In Receivables of £-0.83 Mil as of Jul. 2014. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Ultrasis and its competitors.
Is Ultrasis' Change In Receivables too high?
Ultrasis' current Change In Receivables is £-0.83 Mil.
How does Ultrasis' Change In Receivables compare to competitors?
Ultrasis' Change In Receivables of £-0.83 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Ultrasis and its competitors. Ultrasis's current Change In Receivables is £-0.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultrasis stock overvalued right now?
Ultrasis (LSE:ULT) has a current Change In Receivables of £-0.83 Mil. The current Change In Receivables is £-0.83 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Ultrasis (LSE:ULT), the current Change In Receivables is £-0.83 Mil as of Jul. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ultrasis Business Description

Ultrasis PLC was incorporated in November 23, 1981. The Company through its subsidiary provides healthcare products and services provided via the medium of technology or face to face, that help people maintain, regain and improve their physical, psychological and social well-being. Its product includes Beating the Blues(r), GetFit Wellness, My Brain Solutions, The Relief Series, Drink & Drug Wise, Calm Workplace, and Optimise Me, Screenetics and Joggle.